Cedars-Sinai Medical Care Foundation
Cedars-Sinai Medical Care Foundation was paid $9.75M by Medicaid between Jan 2018 and Dec 2024, across 312 billing codes. Its largest line is 99233, hospital visit by a doctor, follow-up day (complex) — 16% of everything it billed.
33Billing provider infoCEDARS-SINAI MEDICAL CARE FOUNDATION
LOS ANGELES, CA 90048
LOS ANGELES, CA 90048
33aNPI1316984388assigned 05/31/2006
33bProvider typeSpecialist
28Total paid$9.75M
24GClaims1,014,901
24DCodes billed312
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in California
Rank by total paid#17 of 1,230
Median peer was paid$51K
This provider vs. median190×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 191,844 | $1.31M | |
| 2019 | 170,125 | $1.61M | |
| 2020 | 174,817 | $1.59M | |
| 2021 | 216,412 | $1.62M | |
| 2022 | 88,177 | $1.16M | |
| 2023 | 75,082 | $1.23M | |
| 2024incomplete | 98,444 | $1.23M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 16% | 45,760 | 12,116 | $1.52M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.6% | 29,877 | 27,290 | $737K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 5.8% | 25,267 | 8,178 | $563K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 5.7% | 21,888 | 20,605 | $551K |
| 99223 | Prolong inpt eval add15 m | 4.9% | 8,776 | 7,423 | $477K |
| 88350 | 4.7% | 5,324 | 4,598 | $454K | |
| 88348 | 3.4% | 3,876 | 3,687 | $331K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2.8% | 6,779 | 6,653 | $270K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.5% | 15,417 | 14,271 | $240K |
| 88313 | 2.4% | 6,106 | 5,807 | $233K | |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | 2.2% | 1,845 | 1,843 | $214K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.0% | 7,149 | 6,707 | $199K |
300 more codes
| 99239 | Hospital discharge day management, more than 30 minutes | 1.8% | 5,510 | $180K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.8% | 108,325 | $173K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.6% | 72,999 | $153K |
| 88346 | 1.5% | 5,578 | $150K | |
| 99222 | Initial hospital care, per day, moderate complexity | 1.3% | 3,369 | $124K |
| 88342 | 1.2% | 6,544 | $119K | |
| 88307 | 1.1% | 3,381 | $106K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 3,782 | $95K |
| 86923 | <1% | 2,604 | $95K | |
| 83735 | <1% | 35,654 | $86K | |
| 80053 | Comprehensive metabolic panel | <1% | 32,278 | $86K |
| 83880 | <1% | 11,031 | $86K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 5,909 | $85K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 3,292 | $78K |
| 88341 | <1% | 4,023 | $76K | |
| 99205 | Prolong outpt/office vis | <1% | 2,092 | $74K |
| 85027 | <1% | 39,347 | $74K | |
| 84484 | <1% | 14,828 | $66K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 9,427 | $64K |
| 87040 | <1% | 14,614 | $58K | |
| 80197 | <1% | 12,093 | $56K | |
| 88189 | <1% | 1,690 | $55K | |
| 88108 | <1% | 4,456 | $54K | |
| 80076 | <1% | 28,794 | $54K | |
| 83605 | <1% | 18,910 | $53K | |
| 82330 | <1% | 6,820 | $52K | |
| 93970 | <1% | 2,227 | $49K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 747 | $43K |
| 93000 | <1% | 4,800 | $43K | |
| 20610 | <1% | 1,713 | $42K | |
| 90961 | <1% | 451 | $42K | |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | <1% | 352 | $41K |
| 84100 | <1% | 21,630 | $40K | |
| 85730 | <1% | 20,898 | $39K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,196 | $33K |
| J0897 | Injection, denosumab, 1 mg | <1% | 66 | $33K |
| 99221 | <1% | 1,240 | $31K | |
| 84165 | <1% | 8,488 | $31K | |
| 86850 | <1% | 10,153 | $29K | |
| 85060 | <1% | 2,311 | $28K | |
| 86334 | <1% | 7,143 | $28K | |
| 85610 | <1% | 20,482 | $28K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 3,325 | $27K |
| 82962 | <1% | 6,297 | $25K | |
| 99255 | <1% | 266 | $24K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,531 | $23K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 796 | $22K |
| 87077 | <1% | 8,545 | $22K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 1,827 | $21K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 1,626 | $19K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 6,380 | $19K |
| 83690 | <1% | 16,425 | $19K | |
| 87081 | <1% | 7,697 | $18K | |
| 88360 | <1% | 870 | $17K | |
| 81001 | <1% | 19,693 | $17K | |
| 88312 | <1% | 1,151 | $17K | |
| 88304 | <1% | 1,954 | $17K | |
| 87088 | <1% | 5,841 | $16K | |
| 80202 | <1% | 5,548 | $16K | |
| 86480 | <1% | 1,054 | $16K | |
| 93320 | <1% | 1,121 | $15K | |
| 80502 | <1% | 569 | $15K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,649 | $14K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,153 | $14K |
| 86901 | <1% | 9,916 | $14K | |
| 87070 | <1% | 5,893 | $14K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 642 | $13K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 3,523 | $13K |
| G0452 | Molecular pathology procedure; physician interpretation and report | <1% | 1,307 | $12K |
| 89060 | <1% | 2,335 | $12K | |
| 80061 | Lipid panel | <1% | 3,773 | $12K |
| 83615 | <1% | 4,593 | $11K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,072 | $11K |
| 85520 | <1% | 2,679 | $11K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,245 | $10K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 176 | $10K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,182 | $10K |
| 89051 | <1% | 2,574 | $9K | |
| 86900 | <1% | 10,075 | $9K | |
| 82728 | <1% | 3,697 | $9K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,144 | $9K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 333 | $9K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 71 | $9K |
| 87186 | <1% | 4,367 | $9K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,336 | $9K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 268 | $8K |
| 99310 | Prolong nursin fac eval 15m | <1% | 435 | $8K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 213 | $8K |
| 85379 | <1% | 4,671 | $7K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 530 | $7K |
| 99443 | <1% | 83 | $7K | |
| 87340 | <1% | 3,700 | $7K | |
| 84166 | <1% | 2,194 | $7K | |
| 85576 | <1% | 598 | $7K | |
| 86335 | <1% | 1,806 | $7K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 176 | $7K |
| 88309 | <1% | 145 | $6K | |
| 83550 | <1% | 4,185 | $6K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 338 | $6K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 132 | $6K |
| 87205 | <1% | 3,826 | $6K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 714 | $6K |
| 86235 | <1% | 364 | $6K | |
| 86803 | <1% | 1,857 | $6K | |
| 99306 | Prolong nursin fac eval 15m | <1% | 193 | $6K |
| 80074 | <1% | 812 | $5K | |
| 90662 | <1% | 667 | $5K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 643 | $5K |
| 83540 | <1% | 4,535 | $5K | |
| 99254 | <1% | 75 | $5K | |
| 88381 | <1% | 266 | $5K | |
| 84703 | <1% | 6,034 | $5K | |
| 87102 | <1% | 1,633 | $5K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 13 | $5K |
| 83883 | <1% | 800 | $5K | |
| 83970 | <1% | 652 | $5K | |
| 86077 | <1% | 266 | $5K | |
| 86704 | <1% | 1,769 | $5K | |
| 87075 | <1% | 944 | $5K | |
| 85384 | <1% | 1,074 | $5K | |
| 82378 | <1% | 1,505 | $5K | |
| 99497 | <1% | 375 | $5K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 688 | $5K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 2,433 | $5K |
| 87015 | <1% | 2,256 | $4K | |
| 82550 | <1% | 3,402 | $4K | |
| 93325 | <1% | 1,402 | $4K | |
| 99442 | <1% | 90 | $4K | |
| 80047 | <1% | 1,355 | $4K | |
| 82784 | <1% | 1,086 | $4K | |
| 99217 | <1% | 151 | $4K | |
| 82803 | <1% | 508 | $4K | |
| 59025 | Fetal non-stress test | <1% | 154 | $3K |
| 74178 | <1% | 67 | $3K | |
| 51798 | <1% | 491 | $3K | |
| 84134 | <1% | 822 | $3K | |
| 87400 | <1% | 1,112 | $3K | |
| 87536 | <1% | 240 | $3K | |
| 82570 | <1% | 1,800 | $3K | |
| 86360 | <1% | 437 | $3K | |
| 86359 | <1% | 497 | $3K | |
| 87486 | <1% | 334 | $3K | |
| 73030 | <1% | 463 | $3K | |
| 93351 | <1% | 25 | $3K | |
| 87581 | <1% | 313 | $2K | |
| 83010 | <1% | 701 | $2K | |
| 87522 | Neg quan hep c or qual rna | <1% | 331 | $2K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 31 | $2K |
| 86039 | <1% | 943 | $2K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 529 | $2K |
| 77080 | <1% | 300 | $2K | |
| 82607 | <1% | 680 | $2K | |
| 87116 | <1% | 653 | $2K | |
| 86706 | <1% | 820 | $2K | |
| 73562 | <1% | 439 | $2K | |
| 82533 | <1% | 563 | $2K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 13 | $2K |
| 73564 | <1% | 348 | $2K | |
| 83935 | <1% | 1,232 | $2K | |
| 84439 | <1% | 1,163 | $2K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 999 | $2K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 54 | $2K |
| 88311 | <1% | 1,420 | $2K | |
| 77066 | Tomosynthesis, mammo | <1% | 55 | $2K |
| 85390 | <1% | 56 | $2K | |
| 92557 | <1% | 104 | $1K | |
| 85007 | <1% | 2,353 | $1K | |
| 86225 | <1% | 505 | $1K | |
| 88300 | <1% | 582 | $1K | |
| 82150 | <1% | 689 | $1K | |
| 84300 | <1% | 838 | $1K | |
| 88331 | <1% | 149 | $1K | |
| 84550 | <1% | 1,423 | $1K | |
| 86256 | <1% | 208 | $1K | |
| 72141 | <1% | 54 | $1K | |
| 73130 | <1% | 367 | $1K | |
| 86592 | <1% | 1,144 | $1K | |
| 71270 | <1% | 27 | $1K | |
| 73221 | <1% | 82 | $1K | |
| 93016 | <1% | 86 | $1K | |
| 82105 | <1% | 269 | $1K | |
| 99307 | <1% | 98 | $997.96 | |
| 86300 | <1% | 290 | $951.22 | |
| 77065 | Tomosynthesis, mammo | <1% | 27 | $944.81 |
| 93971 | <1% | 152 | $933.74 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 106 | $921.64 |
| 86644 | <1% | 179 | $890.97 | |
| 88377 | <1% | 90 | $888.33 | |
| 99220 | <1% | 14 | $885.98 | |
| 88185 | <1% | 13 | $875.74 | |
| 99152 | <1% | 97 | $861.10 | |
| 84156 | <1% | 733 | $853.28 | |
| 73110 | <1% | 265 | $844.12 | |
| 93290 | <1% | 66 | $799.25 | |
| 73502 | <1% | 199 | $797.20 | |
| 99304 | <1% | 33 | $795.97 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 118 | $765.16 |
| 31575 | <1% | 66 | $763.89 | |
| 82274 | <1% | 127 | $755.42 | |
| 82140 | <1% | 157 | $747.48 | |
| 92550 | <1% | 103 | $696.72 | |
| 85347 | <1% | 98 | $668.97 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 92 | $665.47 |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 52 | $612.75 |
| 87206 | <1% | 386 | $612.45 | |
| 85046 | <1% | 691 | $597.30 | |
| 93280 | <1% | 33 | $595.82 | |
| 20550 | <1% | 93 | $595.49 | |
| 80320 | <1% | 1,160 | $576.60 | |
| 86780 | <1% | 287 | $571.68 | |
| 93018 | <1% | 86 | $570.27 | |
| 86645 | <1% | 134 | $555.37 | |
| 64483 | <1% | 26 | $541.80 | |
| 82565 | <1% | 555 | $528.90 | |
| 87106 | <1% | 298 | $515.16 | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 13 | $505.64 |
| 81002 | <1% | 514 | $504.59 | |
| 93355 | <1% | 15 | $480.30 | |
| 82947 | <1% | 514 | $472.26 | |
| 86880 | <1% | 267 | $442.40 | |
| 72197 | <1% | 13 | $425.11 | |
| 86922 | <1% | 15 | $418.60 | |
| 84132 | <1% | 564 | $416.08 | |
| 88291 | <1% | 27 | $401.57 | |
| 88368 | <1% | 25 | $398.28 | |
| 84702 | <1% | 458 | $395.75 | |
| 85396 | <1% | 41 | $368.55 | |
| 69210 | <1% | 67 | $360.16 | |
| 11721 | <1% | 46 | $357.50 | |
| 93922 | <1% | 26 | $356.90 | |
| 83930 | <1% | 211 | $339.00 | |
| 86301 | <1% | 58 | $335.67 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 400 | $334.54 |
| 82043 | <1% | 394 | $328.37 | |
| 87103 | <1% | 229 | $325.94 | |
| 76642 | <1% | 43 | $320.75 | |
| 86705 | <1% | 160 | $311.99 | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 25 | $306.21 |
| 85097 | <1% | 26 | $305.27 | |
| 85651 | <1% | 508 | $301.75 | |
| 82247 | <1% | 367 | $280.41 | |
| 73610 | <1% | 81 | $269.29 | |
| 90686 | <1% | 64 | $257.93 | |
| 73630 | <1% | 210 | $239.21 | |
| 72100 | <1% | 163 | $231.91 | |
| 87210 | <1% | 226 | $222.86 | |
| 82272 | <1% | 250 | $220.65 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 133 | $218.32 |
| 87149 | <1% | 25 | $217.31 | |
| 88344 | <1% | 13 | $213.61 | |
| 73560 | <1% | 171 | $207.13 | |
| G0008 | Administration of influenza virus vaccine | <1% | 400 | $206.03 |
| 87184 | <1% | 32 | $201.69 | |
| 76830 | Ultrasound, transvaginal | <1% | 12 | $200.91 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 13 | $197.40 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 97 | $195.58 |
| 64484 | <1% | 13 | $183.81 | |
| 72110 | <1% | 92 | $182.10 | |
| 84157 | <1% | 164 | $168.59 | |
| 82248 | <1% | 273 | $159.72 | |
| 87517 | <1% | 18 | $157.97 | |
| 17110 | <1% | 30 | $155.13 | |
| 71250 | <1% | 13 | $149.12 | |
| 82945 | <1% | 16 | $145.77 | |
| 84436 | <1% | 147 | $138.67 | |
| 82977 | <1% | 320 | $125.74 | |
| 86778 | <1% | 26 | $113.86 | |
| 85014 | <1% | 273 | $106.46 | |
| 86777 | <1% | 48 | $105.94 | |
| 81025 | <1% | 227 | $105.37 | |
| 17000 | <1% | 13 | $101.62 | |
| 96367 | <1% | 35 | $94.96 | |
| 84540 | <1% | 127 | $84.08 | |
| 84295 | <1% | 301 | $81.83 | |
| 85301 | <1% | 24 | $80.76 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 777 | $75.95 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 17 | $62.60 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 15 | $50.05 |
| 72040 | <1% | 26 | $48.24 | |
| 93321 | <1% | 13 | $46.84 | |
| 93880 | <1% | 13 | $46.38 | |
| 73140 | <1% | 18 | $43.06 | |
| 84479 | <1% | 32 | $40.69 | |
| 86022 | <1% | 16 | $29.15 | |
| 11056 | <1% | 13 | $25.07 | |
| 84478 | <1% | 99 | $19.68 | |
| 84460 | <1% | 71 | $17.74 | |
| 84450 | <1% | 71 | $17.36 | |
| 87420 | <1% | 26 | $14.28 | |
| 82390 | <1% | 13 | $13.95 | |
| 81003 | <1% | 25 | $8.79 | |
| 20611 | <1% | 23 | $3.24 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 14 | $3.06 |
| 73565 | 0% | 71 | $0.00 | |
| 80305 | 0% | 29 | $0.00 | |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | 0% | 12 | $0.00 |
| 17003 | 0% | 12 | $0.00 | |
| 88173 | 0% | 27 | $0.00 | |
| 90656 | 0% | 64 | $0.00 | |
| 90677 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMARTIN, JILL (EXECUTIVE VP)
| Provider | Location | Paid |
|---|---|---|
| Hilltown Healthcare NP Family PLLC | Berne, NY | $130K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.